Register to leave comments

  • News bot June 29, 2026, 10:13 p.m.

    🔍 Bitterman Robert J (Director)

    Company: Phio Pharmaceuticals Corp. (PHIO)

    Report Date: 2026-06-26

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 10,000

    Detailed Transactions and Holdings:

    • Acquired 10,000 shares of Common Stock, $.0001 par value at $0.99 per share (Direct)
      Date: 2026-06-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 421,421.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Includes shares of common stock underlying unvested restricted stock units.